首页 > 抗体蛋白 > 抗体
APC anti-human CD206 (MMR) Antibody
产品名称:
APC anti-human CD206 (MMR) Antibody
产品类别:
抗体
产品编号:
321109
产品应用:
321109
[价格]
规格 价格 库存
25tests ¥ 1788 1

产品详情

Product Details

Verified Reactivity
Human
Antibody Type
Monoclonal
Host Species
Mouse
Immunogen
Purified human mannose receptor
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration
Lot-specific (to obtain lot-specific concentration, please enter the lot number in our Concentration and Expiration Lookup or Certificate of Analysis online tools.)
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 ?l per million cells in 100 ?l staining volume or 5 ?l per 100 ?l of whole blood.

Excitation Laser
Red Laser (633 nm)
Application Notes

The 15-2 antibody blocks the interaction of MMR with its ligand, and inhibits mannose receptor-mediated degradation of t-PA by macrophages. Additional reported applications of this antibody (for the relevant formats) include: Western blotting1, blocking of ligand binding1,2, immunofluorescence3, and immunohistochemical staining of acetone-fixed frozen tissue sections1. The Utra-LEAF? purified antibody (Endotoxin < 0.01 EU/?g, Azide-Free, 0.2 ?m filtered) is recommended for functional assays (Cat. No. 321149 and 321150).

Application References

(PubMed link indicates BioLegend citation)
  1. Noorman F, et al. 1997. J. Leukocyte Biol. 61:63. (WB, IHC, Block)
  2. Barrett-Bergshoeff M, et al. 1997. Thromb Haemost. 77:718. (Block)
  3. Kato M, et al. 2007. J. Immunol. 179:6052. (IF)
Product Citations
  1. Yoshimura T, et al. 2013. PLoS One. 8:e58791. PubMed
  2. Wang X, et al. 2019. Cell Res. 29:787. PubMed
  3. Cui J, et al. 2021. J Cell Mol Med. 25:5586. PubMed
  4. Murugesan G, et al. 2022. Biomedicines. 10:. PubMed
  5. Alcántara‐Hernández M et al. 2017. Immunity. 47(6):1037-1050 . PubMed
  6. Wang F, et al. 2018. Oncogenesis. 7:41. PubMed
  7. Song D, et al. 2021. Commun Biol. 4:500. PubMed
  8. de Tymowski C et al. 2019. Cell reports. 27(3):762-775 . PubMed
  9. Bekere I, et al. 2021. PLoS Pathog. 17:e1010074. PubMed
  10. Hou ZH, et al. 2020. Am J Physiol Cell Physiol. 318:C649. PubMed
  11. Wu T, et al. 2022. Cell Death Dis. 13:624. PubMed
  12. Sohrabi Y, et al. 2020. Front Immunol. 11:353. PubMed
  13. Vijayakumar B, et al. 2022. Immunity. . PubMed
  14. Yang L, et al. 2020. Cell Stem Cell. 27(1):125-136. PubMed
  15. Wang X, et al. 2021. Front Physiol. 12:644903. PubMed
  16. Cui L, et al. 2021. Am J Reprod Immunol. 86:e13436. PubMed
  17. Nguyen A, et al. 2014. J Biol Chem. 289:1688. PubMed
  18. Shinohara H, et al. 2017. J Immunol. 10.4049/jimmunol.1700167. PubMed
  19. Terenzi DC, et al. 2021. STAR Protoc. 2:100311. PubMed
  20. Edin S, et al. 2013. PLoS One. 18:74982. PubMed
  21. Unger A et al. 2018. Frontiers in immunology. 1.364583333 . PubMed
  22. Warmuth S, et al. 2022. Oncoimmunology. 10:2004661. PubMed
  23. Lundholm M, et al. 2015. Sci Rep. 5: 15651. PubMed
  24. Sohrabi Y, et al. 2019. Front Immunol. 9:3155. PubMed
  25. Sefik E, et al. 2021. Nat Biotechnol. . PubMed
  26. Blaszczak AM, et al. 2019. J Diabetes Res. 2019:8124563. PubMed
  27. Arlt A, et al. 2020. Mol Oncol. 14:571. PubMed
  28. O'Regan N, et al. 2014. PLoS Negl Trop Dis. 8:3206. PubMed
  29. Deng W, et al. 2015. Clin Immunol. . PubMed
  30. Bravo-Flores E, et al. 2018. Int J Mol Sci. 19:E1074. PubMed
  31. Khan A, et al. 2022. Commun Biol. 5:480. PubMed
  32. Li Z, et al. 2020. J Immunol. 2589:204. PubMed
  33. Ray SC, et al. 2018. J Immunol. 200:3568. PubMed
  34. Liu Y, et al. 2022. Clin Transl Med. 12:e654. PubMed
  35. Stempin CC, et al. 2021. Cancers (Basel). 13:. PubMed
  36. Que Y, et al. 2021. Front Immunol. 12:653030. PubMed
  37. Wang YJ, et al. 2021. Sci Rep. 11:8054. PubMed
  38. Zhang B, et al. 2020. Cell Death Dis. 0.973611111. PubMed
  39. Li B, et al. 2019. Oncogenesis. 8:17. PubMed
RRID
AB_571884 (BioLegend Cat. No. 321109) AB_571885 (BioLegend Cat. No. 321110)

Antigen Details

Structure
Type I membrane protein, Pattern Recognition Receptor (PRR) family, C-type lectin superfamily, 162-175 kD
Distribution

Macrophages, dendritic cells, hepatic and lymphatic endothelial cells

Function
Pathogen binding, facilitate phagocytosis and endocytosis, macrophage activation and antigen presentation
Ligand/Receptor
Mannose, fucose, N-acetyl glucosamine
Cell Type
Dendritic cells, Endothelial cells, Macrophages
Biology Area
Cell Biology, Immunology, Neuroscience, Neuroscience Cell Markers
Molecular Family
CD Molecules
Antigen References

1. Mason D, et al. Eds. 2002. Leukocyte Typing VII. Oxford University Press. p303
2. Wileman TE, et al. 1986. P. Natl. Acad. Sci. USA 83:2501.
3. Apostolopoulos V and McKenzie IF. 2001. Curr. Mol. Med. 1:469.
4. Le Cabec V, et al. 2005. J. Leukocyte Biol. 77:934.
5. Barrett-Bergshoeff M, et al. 1997. Thromb. Haemostatis 77:718.

Gene ID
4360 View all products for this Gene ID
UniProt
View information about CD206 on UniProt.org

联系我们

TEL:021-34661275  点击拨打热线